InspireMD, Inc. (NSPR)
NASDAQ: NSPR · Real-Time Price · USD
2.320
-0.270 (-10.42%)
Apr 28, 2025, 4:00 PM EDT - Market closed
InspireMD Market Cap
InspireMD has a market cap or net worth of $71.07 million as of April 29, 2025. Its market cap has increased by 36.42% in one year.
Market Cap
71.07M
Enterprise Value
38.78M
1-Year Change
36.42%
Ranking
Category
Stock Price
$2.32
Market Cap Chart
Since April 12, 2011, InspireMD's market cap has increased from $54.90M to $71.07M, an increase of 29.46%. That is a compound annual growth rate of 1.86%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 25, 2025 | 76.90M | 12.10% |
Dec 31, 2024 | 68.60M | 13.20% |
Dec 29, 2023 | 60.60M | 741.67% |
Dec 30, 2022 | 7.20M | -70.49% |
Dec 31, 2021 | 24.40M | 93.65% |
Dec 31, 2020 | 12.60M | 223.08% |
Dec 31, 2019 | 3.90M | -35.00% |
Dec 31, 2018 | 6.00M | 500.00% |
Dec 29, 2017 | 1.00M | -72.22% |
Dec 30, 2016 | 3.60M | -47.83% |
Dec 31, 2015 | 6.90M | -77.45% |
Dec 31, 2014 | 30.60M | -62.08% |
Dec 31, 2013 | 80.70M | 5.08% |
Dec 31, 2012 | 76.80M | -32.93% |
Dec 30, 2011 | 114.50M | 108.56% |
View and export this data all the way back to 2011.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 784.84B |
UnitedHealth Group | 383.39B |
Johnson & Johnson | 371.82B |
AbbVie | 337.73B |
Novo Nordisk | 272.76B |
Abbott Laboratories | 224.02B |
AstraZeneca | 214.65B |
Novartis AG | 211.71B |